Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
17-alpha-hydroxylase deficiency is an inherited disorder caused by a mutation in the CYP17A1 gene. This gene provides instructions for making an enzyme called 17-alpha-hydroxylase, which is involved in the production of hormones called androgens. Androgens are responsible for the development of male sexual characteristics. In people with 17-alpha-hydroxylase deficiency, the enzyme is either not produced or does not function properly, leading to a decrease in androgen production. This can cause a variety of symptoms, including ambiguous genitalia in newborns, delayed puberty, infertility, and an increased risk of developing certain types of cancer. Treatment typically involves hormone replacement therapy.
All of the following must be considered when interpreting
clinical findings and are too extensive to be covered on
this site: